Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1.

Journal of Neurochemistry
C ChinD A Kendall

Abstract

The human cannabinoid receptor associated with the CNS (CB1) binds delta9-tetrahydrocannabinol, the psychoactive component of marijuana, and other cannabimimetic compounds. This receptor is a member of the seven transmembrane domain G protein-coupled receptor family and mediates its effects through inhibition of adenylyl cyclase. An understanding of the molecular mechanisms involved in ligand binding and receptor activation requires identification of the active site residues and their role. Lys192 of the third transmembrane domain of the receptor is noteworthy because it is the only nonconserved, charged residue in the transmembrane region. To investigate the properties of this residue, which are important for both ligand binding and receptor activation, we generated mutant receptors in which this amino acid was changed to either Arg (K192R), Gln (K192Q), or Glu (K192E). Wild-type and mutant receptors were stably expressed in Chinese hamster ovary cells and were evaluated in binding assays with the bicyclic cannabinoid CP-55,940 and the aminoalkylindole WIN 55,212-2. We found that only the most conservative change of Lys to Arg allowed retention of binding affinity to CP-55,940, whereas WIN 55,212-2 bound to all of the mutant r...Continue Reading

Citations

Dec 21, 2010·Drug Development Research·Alexander C BertalovitzDebra A Kendall
Jul 7, 2018·Frontiers in Pharmacology·Gemma NavarroRafael Franco
Aug 9, 2005·The Journal of Peptide Research : Official Journal of the American Peptide Society·W XuA Makriyannis
Jul 12, 2001·The Journal of Comparative Neurology·J McPartlandM Glass
Oct 9, 2007·British Journal of Pharmacology·B T McIntoshM E M Kelly
May 26, 2018·Chemical Biology & Drug Design·Cheng LiuWei Fu
Jan 23, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Melisa J WallaceRobert O Messing
Jan 23, 2021·Journal of Biomolecular Structure & Dynamics·AyoOluwa O AderibigbeRobert J Doerksen
Oct 22, 2016·Cell·Tian HuaZhi-Jie Liu
Jan 17, 2016·Analytical Biochemistry·Chaela S PresleyBob M Moore
Feb 12, 1999·Neurobiology of Disease·A C Howlett
Aug 17, 2002·Pharmacology & Therapeutics·Andreas Goutopoulos, Alexandros Makriyannis
Dec 31, 2002·Chemistry and Physics of Lipids·Somnath MukhopadhyayAllyn C Howlett
Apr 6, 2004·Brain Research. Brain Research Reviews·John M McPartland
Dec 22, 2005·Neuroscience·C S LamU Strähle
Dec 4, 2015·Journal of Chemical Information and Modeling·Caitlin ScottRavinder Abrol

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.